Cargando…
Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
BACKGROUND: Aberrant expression of heparanase (Hpa) is associated with apoor prognosis in ovarian and cervical cancer patients. Inhibitors of Hpa can prevent the growth and metastasis of malignant tumor cells, and suramin may be such a compound that has strong anti-proliferative effects on several k...
Autores principales: | Li, HuaPing, Li, HuaLi, Qu, HongJie, Zhao, MingZhu, Yuan, Bo, Cao, MingHua, Cui, JinQuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456706/ https://www.ncbi.nlm.nih.gov/pubmed/26052253 http://dx.doi.org/10.1186/s12935-015-0196-y |
Ejemplares similares
-
Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells
por: Song, Yanan, et al.
Publicado: (2016) -
Downregulation of calcineurin activity in cervical carcinoma
por: Padma, S, et al.
Publicado: (2005) -
Melatonin enhances TNF-α-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis
por: Zhao, Qinghe, et al.
Publicado: (2019) -
Downregulation of microRNA-21 inhibited radiation-resistance of esophageal squamous cell carcinoma
por: Li, Fang, et al.
Publicado: (2018) -
miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1
por: Hua, Shengni, et al.
Publicado: (2019)